Filter your results
- 1
- 1
- 2
- 2
- 1
- 1
- 2
- 2
- 2
- 1
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
IGF2/IR/IGF1R pathway in tumor cells and myofibroblasts mediates resistance to EGFR inhibition in cholangiocarcinomaClinical Cancer Research, 2018, 24 (17), pp.4282-4296. ⟨10.1158/1078-0432.CCR-17-3725⟩
Journal articles
hal-01808092v1
|
||
|
Cholangiocarcinoma 2020: the next horizon in mechanisms and managementNature reviews. Gastroenterology & hepatology, 2020, 17 (9), pp.557-588. ⟨10.1038/s41575-020-0310-z⟩
Journal articles
hal-03106830v1
|